Xiaofeng Shi | Medicine and Dentistry | Research Excellence Award

Xiaofeng Shi | Medicine and Dentistry | Research Excellence Award

The Second Affiliated Hospital of Nanjing Medical University | China

Dr. Xiaofeng Shi is a Chinese medical professional and researcher with a strong academic background in medicine and hematology. He earned his Bachelor’s degree from Jiangsu University, followed by a Master’s degree from the School of Medicine at Suzhou University. He later completed his doctoral studies in the Department of Hematology at Shanghai Jiao Tong University School of Medicine. His academic training reflects a focused expertise in medical sciences, particularly in the field of hematology, contributing to clinical research and healthcare advancement.

Citation Metrics (Scopus)

600450

300

150

0

Citations
563
Documents
51
h-index
10

VIEW SCOPUS PROFILE

Featured Publications


Endothelial Activation and Stress Index Serves as a Predictor for Survival in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis

– American Journal of Hematology, 2025

Nomogram for predicting the 30- and 90-day prognoses of hemophagocytic lymphohistiocytosis patients: a multicenter and retrospective study

– Annals of Hematology, 2025

Evaluation of treatment for diffuse large B-cell lymphoma using plasma D-dimer levels

– Scientific Reports, 2025

Advances in the Diagnosis and Treatment of Myeloproliferative Neoplasms (MPNS)

– Review, 2025

ITGA2B/ITGB3-Related Macrothrombocytopenia Associated With Gain-of-Function Mutations in ITGA2B or ITGB3 Genes

– Review, 2025

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

Fabio Sallustio | Medicine and Dentistry | Research Excellence Award

University of Bari Aldo Moro | Italy

Prof. Fabio Sallustio is an Associate Professor in Applied Medical Technical Science at the University of Bari “Aldo Moro,” where he conducts advanced research in renal biology and kidney diseases. His work primarily focuses on the genomic and functional characterization of adult renal stem/progenitor cells and their role in kidney repair, as well as the cellular and molecular mechanisms underlying kidney disorders, particularly IgA nephropathy. He has made significant contributions to understanding how renal progenitor cells activate reparative processes, including identifying key pathways such as Toll-like receptor 2–mediated signaling and their role in tissue regeneration, fibrosis prevention, and immunomodulation. In parallel, his research on IgA nephropathy has advanced knowledge of disease pathogenesis through the identification of dysregulated molecular pathways, epigenetic alterations, and genetic variations. He leads a multidisciplinary research team and actively supervises students and doctoral researchers in the fields of medical biotechnology and molecular medicine.

Citation Metrics (Scopus)

30002000

1000

500

0

Citations
2,697
Documents
96
h-index
32

VIEW SCOPUS PROFILE
VIEW Orcid PROFILE
VIEW Google Scholar PROFILE

Featured Publications

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Bruno Mégarbane | Medicine and Dentistry | Research Excellence Award

Université Paris Cité | France

Prof. Bruno Megarbane is a Professor at Université Paris Cité and serves as Head of the Department of Medical and Toxicological Critical Care at Lariboisière University Hospital. He is also a research team leader within the experimental research group at INSERM UMRS-1144. In addition, he acts as the medical head of the regional and national reference centre for chemicals, toxins, and toxicants (CORTOX), contributing to national health preparedness under the French General Direction of Health. His work primarily focuses on clinical toxicology, including drug poisoning, substance abuse, and envenomation.

Citation Metrics (Google Scholar)

40,00030,000

20,000

10,000

0

Citations

35,281

i10-index

402

h-index

90

View Google Scholar Profile
View Scopus Profile
View Orcid Profile
View PubMed Profile

Featured Publications


A communication strategy and brochure for relatives of patients dying in the ICU

– New England Journal of Medicine, 2007 (Cited by 1743)

High versus low blood-pressure target in patients with septic shock

– New England Journal of Medicine, 2014 (Cited by 1474)

Initiation strategies for renal-replacement therapy in the intensive care unit

– New England Journal of Medicine, 2016 (Cited by 1415)

Hydrocortisone plus fludrocortisone for adults with septic shock

– New England Journal of Medicine, 2018 (Cited by 1038)

Wayne McCormick | Medicine and Dentistry | Excellence in Citation Achievement Award

Wayne McCormick | Medicine and Dentistry | Excellence in Citation Achievement Award

University of Washington | United States

Dr. Wayne C. McCormick, MD, MPH, FACP, is a distinguished Professor of Medicine at the University of Washington School of Medicine, where he holds the William Colson Endowed Chair in Gerontology and Geriatric Medicine. As Division Head of Gerontology and Geriatric Medicine, he has provided exceptional leadership in advancing clinical care, education, and research in aging and palliative medicine. A graduate of Washington University Medical School and the University of Washington School of Public Health, Dr. McCormick completed his medical training at Michael Reese Hospital in Chicago, where he served as Chief Medical Resident before joining the University of Washington faculty in 1990. Over his decades-long career, he has made significant contributions to the fields of geriatrics, hospice, and palliative medicine, serving as Program Director of the Palliative Medicine Fellowship and Director of Palliative Care Services at Harborview Medical Center. He has been recognized with numerous honors, including multiple “Top Doctor” awards from Seattle Magazine and the Harborview Cares Service Excellence Award. A Fellow of the American College of Physicians and past president of both the American Academy of Home Care Physicians and the American Geriatrics Society, Dr. McCormick has played a vital role in shaping national standards for elder care and end-of-life practice. His editorial work for leading journals such as the New England Journal of Medicine and Journal of the American Geriatrics Society underscores his scholarly influence. Deeply committed to mentorship, he has guided generations of medical students, residents, and fellows. Through his extensive leadership, teaching, and clinical service, Dr. McCormick has made enduring contributions to improving the quality of life for older adults and advancing excellence in geriatric and palliative medicine.

Profile: Scopus 

Featured Publications

  • Lee, C. S., Gibbons, L. E., Lee, A. Y., Yanagihara, R. T., Blazes, M. S., Lee, M. L., McCurry, S. M., Bowen, J. D., McCormick, W. C., Crane, P. K., & Larson, E. B. (2022). Association between cataract extraction and development of dementia. JAMA Internal Medicine, 182(2), 134-141.

  • Mohammed, A., Gibbons, L. E., Gates, G., Anderson, M. L., McCurry, S. M., McCormick, W., … Larson, E. B. (2022). Association of performance on dichotic auditory tests with risk for incident dementia and Alzheimer dementia. JAMA Otolaryngology–Head & Neck Surgery, 148(1), 20-27.

  • Alzheimer’s Disease Genetics Consortium. (2022). Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90. Scientific Reports, 12(1),

  • Bellenguez, C., Küçükali, F., Jansen, I. E., Amin, N., Ahmad, S., Lovestone, S., Smith, A. D., Warden, D., Wilcock, G., Laitinen, T., van Duijn, C. M., … (and many others) (2022). New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nature Genetics, 54(4), 412-436.

  • Lee, C. S., … (2023). Diabetic retinopathy and dementia association, beyond diabetes severity. American Journal of Ophthalmology.

Firas Abdollah | Medicine and Dentistry | Best Researcher Award

Firas Abdollah | Medicine and Dentistry | Best Researcher Award

Dr Firas Abdollah,Henry Ford Health,United States

Dr. Firas Abdollah is a Clinical Associate Professor and Vice-Chair of Academic and Research at the Vattikuti Urology Institute, Henry Ford Hospital. With dual citizenship in the USA and Italy, he has a distinguished career in urologic oncology and robotic surgery. He specializes in the epidemiology of urologic cancers and the development of predictive tools for cancer outcomes. He has held research and faculty positions at leading institutions, including Wayne State University and Michigan State University. His extensive contributions to urology have earned him numerous awards, and his research has been published in top-tier journals. Dr. Abdollah is also a medical consultant for Intuitive Surgical Inc.

Publication Profile

Orcid

Education

Dr Firas Abdollah began his academic journey at Al Mutamayizeen Secondary School in Baghdad, Iraq, where he completed his Bachelor of Science between 1995 and 1997. He then pursued a Doctor of Medicine degree at the College of Medicine, Baghdad University, graduating in 2003. Following his medical education, he underwent extensive training through internships and residency at San-Raffaele Hospital, University Vita-Salute, in Milan, Italy, from 2004 to 2012. Further advancing his expertise, he completed a prestigious Fellowship in Robotic Urologic Oncology at the Henry Ford Hospital, Vattikuti Urology Institute, in Detroit, Michigan, USA, from 2015 to 2018.

Experience

Associate Professor at Wayne State University, a position he has held since 2020, and also serves as Vice-Chair of Academic and Research at the Vattikuti Urology Institute, Henry Ford Hospital. In addition, he has been a Clinical Associate Professor at Michigan State University since 2022. His extensive experience in medical consulting includes his current role at Intuitive Surgical Inc., California, starting in 2024. Previously, he was a Medical Consultant for the Department of Urology at the Academic Hospital San Raffaele in Milan, Italy, from 2011 to 2013, and served as a Medical Consultant and Advisor for GenomeDx Biosciences in Vancouver, Canada, from 2014 to 2020. His collaboration with KOELIS Inc. in Delaware lasted from 2022 to 2024 through a consulting and research agreement. Dr. [Name] has also been actively involved in research, having worked as a Research Investigator at Henry Ford Hospital, focusing on prognostic models for prostate and bladder cancers from 2014 to 2015. Earlier in his career, he contributed to cancer prognostics and health outcomes research at the University of Montreal in 2010.

Awards & Honors

  • Best Poster Award – Società Italiana di Urologia Annual Congress (2007)
  • Best of AUA/JUA Meeting Award – AUA Annual Meeting, Washington DC (2011)
  • Best Paper – European Urology Resident Corner (2012)
  • Best Poster Award – European Association of Urology Congress (2012, 2013, 2014, 2018)
  • Excellence in Research Award – Southeast Michigan Center for Medical Education (2017)
  • Top 1% in Field for Peer Reviews – Publons (2017)
  • First Place, Fellow Clinical Research – European Association of Urology Congress (2018)

 

Research Focus

  • Epidemiology of Urologic-Oncology Diseases
  • Prostate, Kidney, Bladder, Testicular, and Penile Cancers
  • Development of Prediction Tools for Disease-Specific Mortality and Recurrence
  • Robotic Urologic Oncology and Outcomes Resear

 

Publication
  • 📖 The importance of pelvic lymph node dissection in the elderly: Implications for interpretation of NCCN guidelines
  • 📖 A novel tool for predicting urinary incontinence after radical prostatectomy
  • 📖 Competing risks analysis of long-term survival in node-positive prostate cancer
  • 📖 Predicting pathological outcomes in patients undergoing robot-assisted radical prostatectomy
  • 📖 Testing the impact of adjuvant radiotherapy on overall mortality in prostate cancer patients
  • 📖 External validity of EORTC 30904 in North American patients with renal cell carcinoma